Related references
Note: Only part of the references are listed.Causal analysis approaches in Ingenuity Pathway Analysis
Andreas Kraemer et al.
BIOINFORMATICS (2014)
Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways
Wim Verhaegh et al.
CANCER RESEARCH (2014)
Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome
Flavia Tosi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
A Novel Model to Combine Clinical and Pathway-Based Transcriptomic Information for the Prognosis Prediction of Breast Cancer
Sijia Huang et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
Clinical Significance and Prognostic Value of Pentraxin-3 as Serologic Biomarker for Lung Cancer
Dai Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013
Jing Wang et al.
NUCLEIC ACIDS RESEARCH (2013)
Mitosis Is a Source of Potential Markers for Screening and Survival and Therapeutic Targets in Cervical Cancer
Ana Maria Espinosa et al.
PLOS ONE (2013)
Inhibition of DEPDC1A, a Bad Prognostic Marker in Multiple Myeloma, Delays Growth and Induces Mature Plasma Cell Markers in Malignant Plasma Cells
Alboukadel Kassambara et al.
PLOS ONE (2013)
Pathway-based personalized analysis of cancer
Yotam Drier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A Human Thyroid Cancer Cell Line, DH-14-3, Newly Established from Poorly Differentiated Thyroid Carcinoma
Jin Teshima et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Causal reasoning on biological networks: interpreting transcriptional changes
Leonid Chindelevitch et al.
BIOINFORMATICS (2012)
Assessing statistical significance in causal graphs
Leonid Chindelevitch et al.
BMC BIOINFORMATICS (2012)
In papillary thyroid carcinoma BRAFV600E is associated with increased expression of the urokinase plasminogen activator and its cognate receptor, but not with disease-free interval
Salvatore Ulisse et al.
CLINICAL ENDOCRINOLOGY (2012)
Platelet-derived growth factor receptor-α promotes lymphatic metastases in papillary thyroid cancer
Jingdong Zhang et al.
JOURNAL OF PATHOLOGY (2012)
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
Jens G. Lohr et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
High Expression of the Urokinase Plasminogen Activator and Its Cognate Receptor Associates with Advanced Stages and Reduced Disease-Free Interval in Papillary Thyroid Carcinoma
Salvatore Ulisse et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM
Charles J. Vaske et al.
BIOINFORMATICS (2010)
Frozen robust multiarray analysis (fRMA)
Matthew N. McCall et al.
BIOSTATISTICS (2010)
Orphan receptor GPR110, an oncogene overexpressed in lung and prostate cancer
Amy M. Lum et al.
BMC CANCER (2010)
Osteopontin is a marker for cancer aggressiveness and patient survival
G. F. Weber et al.
BRITISH JOURNAL OF CANCER (2010)
The role of the PAX8/PPARγ fusion oncogene in the pathogenesis of follicular thyroid cancer
N. L. Eberhardt et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
A Phase II Study of Imatinib in Patients with Advanced Anaplastic Thyroid Cancer
Huan T. Ha et al.
THYROID (2010)
A novel signaling pathway impact analysis
Adi Laurentiu Tarca et al.
BIOINFORMATICS (2009)
RAS Mutations Are the Predominant Molecular Alteration in Poorly Differentiated Thyroid Carcinomas and Bear Prognostic Impact
Marco Volante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis
Sam M. Wiseman et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Association of PTEN Gene Methylation With Genetic Alterations in the Phosphatidylinositol 3-Kinase/AKT Signaling Pathway in Thyroid Tumors
Peng Hou et al.
CANCER (2008)
Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis
Gisele Oler et al.
CLINICAL CANCER RESEARCH (2008)
Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular Neoplasias
Gazanfer Belge et al.
GENES CHROMOSOMES & CANCER (2008)
Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis
M. Kanehira et al.
ONCOGENE (2007)
New therapeutic approaches for metastatic thyroid carcinoma
Eric Baudin et al.
LANCET ONCOLOGY (2007)
Pathology and genetics of thyroid carcinoma
Ronald A. Delellis
JOURNAL OF SURGICAL ONCOLOGY (2006)
Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer
Shuiying Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
An aberrant autocrine activation of the platelet-derived growth factor α-receptor in follicular and papillary thyroid carcinoma cell lines
KT Chen et al.
CANCER LETTERS (2006)
Human thyroid carcinoma cell invasion is controlled by the low density lipoprotein receptor-related protein-mediated clearance of urokinase plasminogen activator
Brice Sid et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Mutation of the PIK3CA gene in anaplastic thyroid cancer
G García-Rostán et al.
CANCER RESEARCH (2005)
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness
V Guarino et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
HMGA1 protein overexpression in human breast carcinomas: Correlation with ErbB2 expression
G Chiappetta et al.
CLINICAL CANCER RESEARCH (2004)
Follicular neoplasms of the thyroid - View, biases, and experiences
VA LiVolsi et al.
ADVANCES IN ANATOMIC PATHOLOGY (2004)
RAS point mutations and PAX8-PPARγ rearrangement in thyroid tumors:: Evidence for distinct molecular pathways in thyroid follicular carcinoma
MN Nikiforova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis
J Oh et al.
CELL (2001)
Cyclin D1 overexpression in thyroid carcinomas: Relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index
F Basolo et al.
THYROID (2000)
Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer
YA DeClerck
EUROPEAN JOURNAL OF CANCER (2000)
Share Paper
